TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseases
Закрыть
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
400 0
SM ISO690:2012
ERICKSON, Susan, SULLIVAN, Amy Gallant, BULAT, Nina, CUSHNIR, V., CUŞNIR, Vitalie. TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseases. In: Ocular Surface, 2020, vol. 18, pp. 936-962. ISSN 1542-0124. DOI: https://doi.org/10.1016/j.jtos.2020.05.006
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Ocular Surface
Volumul 18 / 2020 / ISSN 1542-0124

TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseases

DOI:https://doi.org/10.1016/j.jtos.2020.05.006

Pag. 936-962

Erickson Susan1, Sullivan Amy Gallant2, Bulat Nina3, Cushnir V.3, Cuşnir Vitalie3
 
1 Brookline, MA,
2 TFOS, Boston, MA,
3 ”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 15 martie 2021


Rezumat

The mission of the Tear Film & Ocular Surface Society (TFOS) is to advance the research, literacy, and educational aspects of the scientific field of the tear film and ocular surface. Fundamental to fulfilling this mission is the TFOS Global Ambassador program. TFOS Ambassadors are dynamic and proactive experts, who help promote TFOS initiatives, such as presenting the conclusions and recommendations of the recent TFOS DEWS II™, throughout the world. They also identify unmet needs, and propose future clinical and scientific solutions, for management of ocular surface diseases in their countries. This meeting report addresses such needs and solutions for 25 European countries, as detailed in the TFOS European Ambassador meeting in Rome, Italy, in September 2019. 

Cuvinte-cheie
aciclovir, artificial tear, chloramphenicol, corticosteroid, cyclosporine, dexamethasone, diquafosol, eye drops, Fusidic acid, Hyaluronic acid, hydrocortisone, immunomodulating agent, interferon, lifitegrast, lubricating agent, mitomycin, natamycin, nerve growth factor, omega 3 fatty acid, prescription drug